RECITALSLicense, Research and Development Agreement • February 6th, 2002 • Dov Pharmaceutical Inc • Pharmaceutical preparations • New York
Contract Type FiledFebruary 6th, 2002 Company Industry Jurisdiction
Re: The License, Research and Development Agreement dated August 2, 2000 between MethylGene, Inc. (MG) and MGI PHARMA, INC. (MGI) (the “Agreement”)License, Research and Development Agreement • February 24th, 2004 • Mgi Pharma Inc • Pharmaceutical preparations
Contract Type FiledFebruary 24th, 2004 Company IndustryThe purpose of this letter is to amend and capture the current understanding between our companies regarding the status of the above referenced Agreement. With this letter, MethylGene agrees that: